Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis

• Главные авторы: Peng-Fei Wang (Автор), Yang Chen (Автор), Si-Ying Song (Автор), Ting-Jian Wang (Автор), Wen-Jun Ji (Автор), Shou-Wei Li (Автор), Ning Liu (Автор), Chang-Xiang Yan (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2017-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Treatment of cancers with programmed cell death protein 1 (PD-1) pathway inhibitors can lead to immune-related adverse events (irAEs), which could be serious and even fetal. Therefore, clinicians should be aware of the characteristics of irAEs associated with the use of such drugs.Method...